Richard Scolyer
Melanoma Institute Australia; The University of Sydney; Royal Prince Alfred Hospital/NSW Health Pathology, NSW, Australia

Professor Richard Scolyer AO, is Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital; Co-Medical Director, Melanoma Institute Australia; and Conjoint Professor, Faculty of Medicine and Health, The University of Sydney. He provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more 2000 cases annually for opinion from Australasia and internationally. He effectively integrates his clinical practice with leading an award-winning translational melanoma research laboratory. His record includes co-authoring more than 900 peer reviewed publications and/or book-chapters with >87,079 citations and a h-index of 132. Professor Scolyer has presented on more than 430 occasions at conferences throughout the world. Professor Scolyer was awarded an Officer of the Order of Australia, both the 2024 NSW Australians of the Year and 2024 Australians of the Year together with many other awards.
Presentations this author is a contributor to:
Perspectives of health professionals and patients on implementation of a predictive model of response to immunotherapies in advanced melanoma (#54)
12:35 PM
Rehana A Salam
Concurrent Session - Oncology Frontiers
Immunospatial tumour immune microenvironment (isTIME) organisation is associated with recurrence in primary melanoma (#7)
11:50 AM
Grace H Attrill
Concurrent Session - Cancer Immunology
Features of immunotherapy response are prevalent in melanoma brain metastases compared to high grade gliomas (#161)
12:45 PM
Bernadette Pedersen
Lunch & Poster Viewing (Odd Numbers)